Policies to Provisions

GHIAA is a global resource providing research, education, advocacy and support to stakeholders involved with global health agreements and related policies. 

The Global Health Innovation Alliance Accelerator (GHIAA)

We are dedicated to improving the health of the world’s communities through accelerated and improved alliance formation.

The  Global Health Innovation Alliance Accelerator (GHIAA), established in 2017, is an independent resource, curator, interdisciplinary think tank, and consultancy. GHIAA aims to facilitate translation of global health policies into actionable agreement provisions that will address global health challenges by advancing research, development and marketing for new biomedical technologies. To achieve this objective, GHIAA develops and promotes the use of tools and best practices for global health alliance formation. We seek to engage academic, governmental, business, and nonprofit organizations in this collaborative effort. 

global_healt_rep_david_price510 (1)

The  Global Health Innovation Alliance Accelerator (GHIAA), established in 2017, is an independent resource, curator, interdisciplinary think tank, and consultancy. GHIAA aims to facilitate translation of global health policies into actionable agreement provisions that will address global health challenges by advancing research, development and marketing for new biomedical technologies. To achieve this objective, GHIAA develops and promotes the use of tools and best practices for global health alliance formation. We seek to engage academic, governmental, business, and nonprofit organizations in this collaborative effort. 

global_healt_rep_david_price510 (1)
global_healt_rep_david_price510 (1)

The  Global Health Innovation Alliance Accelerator (GHIAA), established in 2017, is an independent resource, curator, interdisciplinary think tank, and consultancy. GHIAA aims to facilitate translation of global health policies into actionable agreement provisions that will address global health challenges by advancing research, development and marketing for new biomedical technologies. To achieve this objective, GHIAA develops and promotes the use of tools and best practices for global health alliance formation. We seek to engage academic, governmental, business, and nonprofit organizations in this collaborative effort. 

Launch of the MAPGuide

We are excited to announce the launch of the GHIAA Master Alliance Provisions Guide (MAPGuide). The MAPGuide is a new tool to help practitioners and policymakers access a curated collection of actual and template contractual provisions from global health agreements that address key principles upon which partnerships are built. The MAPGuide will be updated regularly, and we are seeking additional content in the form of full agreements or individual agreement provisions.

Latest News

  • December 1, 2020

    Glossary of Global Health Agreement Terms

    GHIAA is pleased to announce the publication of its Glossary of Global Health Agreement Terms - a curated collection of often used terms in policies, negotiations and agreements in the global public health field. Our continuing goal is to facilitate the discussions which lead to successful global health transactions and alliances. GHIAA welcomes suggestions of new terms and definitions which are important to the global health policy and transactions community. Read More
  • August 25, 2020

    New grant from the Wellcome Trust

    We are pleased to announce a new grant from the Wellcome Trust to support further development of the MAPGuide. Read More
  • August 11, 2020

    Launch of the MAPGuide

    The GHIAA MAPGuide is now available for public use. We look forward to receiving user feedback as well as additional agreements and provisions to include in the MAPGuide. Read More
  • August 10, 2020

    COVID-19 agreements

    GHIAA is tracking new agreements arising from the development of COVID-19 diagnostics, therapeutics and vaccines with the aim of including COVID-19 agreements in the MAPGuide. GHIAA also recently provided input to an article published in Science on the importance of knowledge transfer for large-scale vaccine manufacturing in the context of COVID-19. Read More